Public Health

COVID without symptoms may be very rare, study finds

In a new study from Uniformed Services University of the Health Sciences, researchers found that healthy, unvaccinated adults who get COVID are unlikely to...

How prevalent COVID-19 taste loss really is

In a new study from Monell Chemical Senses Center, researchers found that the reports of taste loss are genuine and distinguishable from smell loss. Reports...

Vaccine protection up after three COVID-19 vaccine doses

In a new study from CDC, researchers found COVID-19 vaccine protection is increased after three doses but wanes with time since vaccination after receipt...

Antibody quality improves for months after COVID-19 vaccination

In a new study from Washington University in St. Louis, researchers found for at least six months after COVID-19 vaccination, antibodies produced by immune...

This therapy may help treat long COVID

In a new study from Flow Therapy, researchers found in long COVID-19 patients, those who used 15-35 hours of enhanced external counterpulsation (EECP) therapy...

This hormone may prevent COVID-19 death in older women

In a new study from the Univerisity of Helsinki, researchers found an older woman's oestrogen levels may be linked to her chances of dying...

Long COVID could be linked to the effects of virus on vagus nerve

In a new study, researchers found that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked...

3 doses of Pfizer COVID vaccine better than 2, study finds

In a new study from Kaiser Permanente, researchers found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine conferred higher effectiveness against...

Hospitalization for COVID-19 linked to much greater death risk

In a new study from the University of Oxford, researchers found that people who had been hospitalized for COVID-19—and survived for at least one...

The more vaccinated you are, the better your outcome with Omicron

The highly contagious omicron variant of SARS-CoV-2 became the dominant strain in the United States in mid-December 2021, coinciding with a rise in hospitalizations...